![Kole Roybal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kole T.
Roybal is the founder of Arsenal Biosciences, Inc., founded in 2019.
Dr. Roybal is the founder of Dispatch Biotherapeutics, Inc., founded in 2022.
Dr. Roybal is also the founder of Moonlight Bio, Inc...
Dr. Roybal is currently an Advisor at Venrock Associates since 2020.
Actieve functies van Kole Roybal
| Bedrijven | Functie | Begin |
|---|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultant / Adviseur | 01-09-2020 |
Dispatch Biotherapeutics, Inc.
 Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Oprichter | 01-01-2022 |
Eerdere bekende functies van Kole Roybal
| Bedrijven | Functie | Einde |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Health Technology |
